These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 19921505

  • 1. Lipid and inflammatory biomarkers and kidney function decline in type 2 diabetes.
    Lin J, Hu FB, Mantzoros C, Curhan GC.
    Diabetologia; 2010 Feb; 53(2):263-7. PubMed ID: 19921505
    [Abstract] [Full Text] [Related]

  • 2. The association of serum lipids and inflammatory biomarkers with renal function in men with type II diabetes mellitus.
    Lin J, Hu FB, Rimm EB, Rifai N, Curhan GC.
    Kidney Int; 2006 Jan; 69(2):336-42. PubMed ID: 16408124
    [Abstract] [Full Text] [Related]

  • 3. Variability in HbA1c, blood pressure, lipid parameters and serum uric acid, and risk of development of chronic kidney disease in type 2 diabetes.
    Ceriello A, De Cosmo S, Rossi MC, Lucisano G, Genovese S, Pontremoli R, Fioretto P, Giorda C, Pacilli A, Viazzi F, Russo G, Nicolucci A, AMD-Annals Study Group.
    Diabetes Obes Metab; 2017 Nov; 19(11):1570-1578. PubMed ID: 28432733
    [Abstract] [Full Text] [Related]

  • 4. Validating the association between plasma tumour necrosis factor receptor 1 levels and the presence of renal injury and functional decline in patients with Type 2 diabetes.
    Doody A, Jackson S, Elliott JA, Canavan RJ, Godson C, Slattery D, Twomey PJ, McKenna MJ, le Roux CW, Docherty NG.
    J Diabetes Complications; 2018 Jan; 32(1):95-99. PubMed ID: 29122448
    [Abstract] [Full Text] [Related]

  • 5. Circulating adiponectin levels are associated with better glycemic control, more favorable lipid profile, and reduced inflammation in women with type 2 diabetes.
    Mantzoros CS, Li T, Manson JE, Meigs JB, Hu FB.
    J Clin Endocrinol Metab; 2005 Aug; 90(8):4542-8. PubMed ID: 15914524
    [Abstract] [Full Text] [Related]

  • 6. The impact of serum lipids on risk for microangiopathy in patients with type 2 diabetes mellitus.
    Toth PP, Simko RJ, Palli SR, Koselleck D, Quimbo RA, Cziraky MJ.
    Cardiovasc Diabetol; 2012 Sep 14; 11():109. PubMed ID: 22978715
    [Abstract] [Full Text] [Related]

  • 7. Association Between Inflammatory Markers and Progression to Kidney Dysfunction: Examining Different Assessment Windows in Patients With Type 1 Diabetes.
    Baker NL, Hunt KJ, Stevens DR, Jarai G, Rosen GD, Klein RL, Virella G, Lopes-Virella MF, DCCT/EDIC Research Group.
    Diabetes Care; 2018 Jan 14; 41(1):128-135. PubMed ID: 29118060
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Predictors of estimated GFR decline in patients with type 2 diabetes and preserved kidney function.
    Zoppini G, Targher G, Chonchol M, Ortalda V, Negri C, Stoico V, Bonora E.
    Clin J Am Soc Nephrol; 2012 Mar 14; 7(3):401-8. PubMed ID: 22282481
    [Abstract] [Full Text] [Related]

  • 11. Adiponectin is inversely associated with renal function in type 1 diabetic patients.
    Schalkwijk CG, Chaturvedi N, Schram MT, Fuller JH, Stehouwer CD, EURODIAB Prospective Complications Study Group.
    J Clin Endocrinol Metab; 2006 Jan 14; 91(1):129-35. PubMed ID: 16219717
    [Abstract] [Full Text] [Related]

  • 12. Soluble tumor necrosis factor receptor 1 is associated with diminished estimated glomerular filtration rate in colombian patients with type 2 diabetes.
    Gómez-Banoy N, Cuevas V, Higuita A, Aranzález LH, Mockus I.
    J Diabetes Complications; 2016 Jul 14; 30(5):852-7. PubMed ID: 27068267
    [Abstract] [Full Text] [Related]

  • 13. Elevated Serum Uric Acid Is Associated With Greater Risk for Hypertension and Diabetic Kidney Diseases in Obese Adolescents With Type 2 Diabetes: An Observational Analysis From the Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) Study.
    Bjornstad P, Laffel L, Lynch J, El Ghormli L, Weinstock RS, Tollefsen SE, Nadeau KJ, TODAY Study Group.
    Diabetes Care; 2019 Jun 14; 42(6):1120-1128. PubMed ID: 30967435
    [Abstract] [Full Text] [Related]

  • 14. Validation of a protein biomarker test for predicting renal decline in type 2 diabetes: The Fremantle Diabetes Study Phase II.
    Peters KE, Davis WA, Ito J, Bringans SD, Lipscombe RJ, Davis TME.
    J Diabetes Complications; 2019 Dec 14; 33(12):107406. PubMed ID: 31669066
    [Abstract] [Full Text] [Related]

  • 15. High Baseline Levels of Tumor Necrosis Factor Receptor 1 Are Associated With Progression of Kidney Disease in Indigenous Australians With Diabetes: The eGFR Follow-up Study.
    Barr ELM, Barzi F, Hughes JT, Jerums G, Hoy WE, O'Dea K, Jones GRD, Lawton PD, Brown ADH, Thomas M, Ekinci EI, Sinha A, Cass A, MacIsaac RJ, Maple-Brown LJ.
    Diabetes Care; 2018 Apr 14; 41(4):739-747. PubMed ID: 29367427
    [Abstract] [Full Text] [Related]

  • 16. Non-transferrin-bound iron is associated with biomarkers of oxidative stress, inflammation and endothelial dysfunction in type 2 diabetes.
    Aljwaid H, White DL, Collard KJ, Moody AJ, Pinkney JH.
    J Diabetes Complications; 2015 Apr 14; 29(7):943-9. PubMed ID: 26104728
    [Abstract] [Full Text] [Related]

  • 17. Moderate alcohol intake and markers of inflammation and endothelial dysfunction among diabetic men.
    Shai I, Rimm EB, Schulze MB, Rifai N, Stampfer MJ, Hu FB.
    Diabetologia; 2004 Oct 14; 47(10):1760-7. PubMed ID: 15502925
    [Abstract] [Full Text] [Related]

  • 18. Chronic kidney disease categories and renal-cardiovascular outcomes in type 2 diabetes without prevalent cardiovascular disease: a prospective cohort study (JDDM25).
    Yokoyama H, Araki S, Haneda M, Matsushima M, Kawai K, Hirao K, Oishi M, Sugimoto K, Sone H, Maegawa H, Kashiwagi A, Japan Diabetes Clinical Data Management Study Group.
    Diabetologia; 2012 Jul 14; 55(7):1911-8. PubMed ID: 22476921
    [Abstract] [Full Text] [Related]

  • 19. Increased urinary albumin excretion, endothelial dysfunction, and chronic low-grade inflammation in type 2 diabetes: progressive, interrelated, and independently associated with risk of death.
    Stehouwer CD, Gall MA, Twisk JW, Knudsen E, Emeis JJ, Parving HH.
    Diabetes; 2002 Apr 14; 51(4):1157-65. PubMed ID: 11916939
    [Abstract] [Full Text] [Related]

  • 20. Soluble E-selectin, leptin, triglycerides, and insulin resistance in nonobese Japanese type 2 diabetic patients.
    Taniguchi A, Fukushima M, Nakai Y, Kuroe A, Yamano G, Yanagawa T, Ohgushi M, Ohya M, Yoshii S, Taki Y, Seino Y.
    Metabolism; 2005 Mar 14; 54(3):376-80. PubMed ID: 15736116
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.